Cell cycle-dependent induction of homologous recombination by a tightly regulated I-SceI fusion protein

PLoS One. 2011 Mar 9;6(3):e16501. doi: 10.1371/journal.pone.0016501.

Abstract

Double-strand break repair is executed by two major repair pathways: non-homologous end joining (NHEJ) and homologous recombination (HR). Whereas NHEJ contributes to the repair of ionizing radiation (IR)-induced double strand breaks (DSBs) throughout the cell cycle, HR acts predominantly during the S and G2 phases of the cell cycle. The rare-cutting restriction endonuclease, I-SceI, is in common use to study the repair of site-specific chromosomal DSBs in vertebrate cells. To facilitate analysis of I-SceI-induced DSB repair, we have developed a stably expressed I-SceI fusion protein that enables precise temporal control of I-SceI activation, and correspondingly tight control of the timing of onset of site-specific chromosome breakage. I-SceI-induced HR showed a strong, positive linear correlation with the percentage of cells in S phase, and was negatively correlated with the G1 fraction. Acute depletion of BRCA1, a key regulator of HR, disrupted the relationship between S phase fraction and I-SceI-induced HR, consistent with the hypothesis that BRCA1 regulates HR during S phase.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • BRCA1 Protein / metabolism
  • Cell Cycle / drug effects
  • Cell Cycle / genetics*
  • Cell Line, Tumor
  • Chromosome Breakage / drug effects
  • Deoxyribonucleases, Type II Site-Specific / metabolism*
  • Enzyme Activation / drug effects
  • Green Fluorescent Proteins / metabolism
  • Humans
  • Receptors, Estrogen / metabolism
  • Recombinant Fusion Proteins / metabolism*
  • Recombination, Genetic* / drug effects
  • S Phase / drug effects
  • Tamoxifen / analogs & derivatives
  • Tamoxifen / pharmacology
  • Time Factors

Substances

  • BRCA1 Protein
  • Receptors, Estrogen
  • Recombinant Fusion Proteins
  • Tamoxifen
  • Green Fluorescent Proteins
  • afimoxifene
  • Deoxyribonucleases, Type II Site-Specific